Comparison of Short-Term Choroidal Thickness and Retinal Morphological Changes after Intravitreal Anti-VEGF Therapy with Ranibizumab or Aflibercept in Treatment-Naive Eyes.

CONCLUSIONS: CT reduction is greater in aflibercept-treated eyes, and type 3 lesions show the greatest thickness decrease. The post-treatment frequency of dry macula, evaluated by qualitative parameters, is higher in aflibercept-treated eyes, but is not correlated with CT change. PMID: 29166140 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29166140?dopt=Abstract

Source: Current Eye Research - November 22, 2017 Category: Opthalmology Authors: Gharbiya M, Giustolisi R, Marchiori J, Bruscolini A, Mallone F, Fameli V, Nebbioso M, Abdolrahimzadeh S Tags: Curr Eye Res Source Type: research